Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.5 EUR | -1.27% |
|
+10.10% | -1.98% |
06-18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
06-13 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
FYB202
71.5
%
| 3 | 6.1 % | 37 | 71.5 % | +1,350.16% |
FYB201
28.5
%
| 12 | 28.5 % | 15 | 28.5 % | +22.76% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
67.2
%
| 10 | 24.6 % | 52 | 67.2 % | +399.81% |
Germany
32.8
%
| 32 | 75.4 % | 25 | 32.8 % | -20.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 30/09/16 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 31/03/23 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Sabrina Müller
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 53 | 31/05/22 | |
Meike Heger
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Klaus Röhrig
BRD | Director/Board Member | 47 | 09/12/20 |
Wolfgang Essler
CHM | Chairman | - | 24/07/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,656,902 | 7,446,341 ( 42.17 %) | 0 | 42.17 % |
Company contact information
Formycon AG
Fraunhoferstraße 15 Martinsried, Planegg
82152, Munich
+49 89 864 667 100
http://formycon.com![address Formycon AG(FYB)](https://cdn.zonebourse.com/static/address/50917220.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.44B | |
+37.63% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- Company Formycon AG